Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Earnings Data
Report Date
Feb 26, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
2.01Last Year’s EPS
1.63Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 07, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a strong performance by ANI Pharmaceuticals, with record-breaking revenue and significant growth driven by the Rare Disease and Generics segments. Despite challenges in the ILUVIEN segment and Medicare funding affecting Retina products, the company raised its financial guidance and demonstrated robust cash flow and debt management.Company Guidance
Record Revenue and Growth
ANI Pharmaceuticals achieved record revenue, adjusted EBITDA, and adjusted EPS in Q3 2025. Total company revenues increased by 54% year-over-year and 46% on an organic basis.
Cortrophin Gel Revenue Surge
Cortrophin Gel net revenue nearly doubled compared to Q3 2024, contributing to a 70% year-over-year growth in adjusted EBITDA. Cortrophin Gel is expected to grow 75% to 78% year-over-year to generate revenues of $347 million to $352 million.
Generics Business Performance
The Generics business had a strong performance due to an opportunistic partner generic launch, leading to expected Generics growth for the full year in the low 20% range.
Increased Financial Guidance
ANI Pharmaceuticals raised its full-year 2025 financial guidance, expecting net revenues to grow 39% to 42% and adjusted EBITDA between 42% and 46% compared to 2024.
Cash Flow and Debt Management
ANI Pharmaceuticals ended Q3 with $262.6 million in unrestricted cash, up from $217.8 million in Q2, and reduced net leverage to 1.7x trailing 12-month adjusted EBITDA.
ANIP Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ANIP Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 07, 2025 | $90.23 | $90.43 | +0.22% |
Aug 08, 2025 | $69.01 | $81.48 | +18.07% |
May 09, 2025 | $71.53 | $66.30 | -7.31% |
Feb 28, 2025 | $54.58 | $61.89 | +13.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does ANI Pharmaceuticals Inc (ANIP) report earnings?
ANI Pharmaceuticals Inc (ANIP) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
What is ANI Pharmaceuticals Inc (ANIP) earnings time?
ANI Pharmaceuticals Inc (ANIP) earnings time is at Feb 26, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ANIP EPS forecast?
ANIP EPS forecast for the fiscal quarter 2025 (Q4) is 2.01.